On October 23, MaxLinear fell 6.44% in Regular Trading, trading at $59.374 per share, with turnover of $37.5865 million.
The move came even after the company reported third-quarter results and fourth-quarter revenue guidance above Wall Street expectations, indicating that investor caution around the durability of the recovery continued to weigh on the stock.
MaxLinear reported adjusted EPS of $0.62 for the quarter ended September 30, up from $0.14 a year earlier and above consensus expectations of $0.55-$0.56. Revenue rose 72% year over year to $218.1 million, ahead of expectations ranging from about $211.2 million to $214.9 million. For the fourth quarter, the company guided revenue to $240 million-$260 million, above the $226.6 million market expectation. Even so, the stock remained under pressure in trading after the release, reflecting ongoing market disagreement over the sustainability of the business rebound and the margin path.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments